Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Wiseman

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Clinical Pharmacokinetics|March 27, 2014
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patientsDaniel R Getts, William G Kramer, Alexander C Wiseman, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 24, 2017
De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive RegimensZain Mithani, Jane Gralla, Oluwafisayo Adebiyi, et al.
Clinical Transplants|August 19, 2015
High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported CohortsJavier Alfonso, Jane Gralla, Patrick Klem, et al.
Transplantation|March 16, 2011
Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodesJames E Cooper, Jane Gralla, Linda Cagle, et al.
Journal of Renal Care|October 3, 2018
Academic achievement and employment in young adults with end-stage kidney diseasePeter D Murray, Maximillian H Brodermann, Jane Gralla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 2006
Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratificationEric M Gibney, Linda R Cagle, Brian Freed, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2004
Kidney transplantation for systemic sclerosis improves survival and may modulate disease activityEric M Gibney, Chirag R Parikh, Alkesh Jani, et al.
Current Opinion in Nephrology and Hypertension|February 12, 2024
Novel indications for referral and care for simultaneous liver kidney transplant recipientsErik L Lum, Suphamai Bunnapradist, Alexander C Wiseman, et al.
Transplantation|November 26, 2009
Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipientsPatrick Klem, James E Cooper, Andrew S Weiss, et al.
Transplantation|July 3, 2010
An analysis of the lack of donor pancreas utilization from younger adult organ donorsAlexander C Wiseman, Jennifer L Wainright, Elizabeth Sleeman, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|March 27, 2014
The pharmacokinetics and pharmacodynamics of TOL101, a murine IgM anti-human αβ T cell receptor antibody, in renal transplant patientsDaniel R Getts, William G Kramer, Alexander C Wiseman, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 24, 2017
De Novo Donor-Specific Antibody Formation in Tacrolimus-Based, Mycophenolate Versus Mammalian Target of Rapamycin Immunosuppressive RegimensZain Mithani, Jane Gralla, Oluwafisayo Adebiyi, et al.
Clinical Transplants|August 19, 2015
High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported CohortsJavier Alfonso, Jane Gralla, Patrick Klem, et al.
Transplantation|March 16, 2011
Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodesJames E Cooper, Jane Gralla, Linda Cagle, et al.
Journal of Renal Care|October 3, 2018
Academic achievement and employment in young adults with end-stage kidney diseasePeter D Murray, Maximillian H Brodermann, Jane Gralla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 2006
Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratificationEric M Gibney, Linda R Cagle, Brian Freed, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2004
Kidney transplantation for systemic sclerosis improves survival and may modulate disease activityEric M Gibney, Chirag R Parikh, Alkesh Jani, et al.
Current Opinion in Nephrology and Hypertension|February 12, 2024
Novel indications for referral and care for simultaneous liver kidney transplant recipientsErik L Lum, Suphamai Bunnapradist, Alexander C Wiseman, et al.
Transplantation|November 26, 2009
Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipientsPatrick Klem, James E Cooper, Andrew S Weiss, et al.
Transplantation|July 3, 2010
An analysis of the lack of donor pancreas utilization from younger adult organ donorsAlexander C Wiseman, Jennifer L Wainright, Elizabeth Sleeman, et al.
Pageof 6